Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paromomycin IM Injection for Visceral Leishmaniasis in Bangladesh
NCT01328457Phase 3Completed
- Sponsor
- PATH
- Start
- Jan 2011
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paromomycin in visceral leishmaniasis (VL), sponsored by PATH. Started Jan 2011; status: completed.
02
Drugs
paromomycin
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT01328457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328457.